Belzutifan Regimens Show Promise in RCC as Frontline IO/TKI Armamentarium Expands
Nikhil A. Gopal, MD, discusses the benefit of belzutifan in addition to effective immunotherapy-based regimens in advanced RCC.
Source: onclive.com
Page 6 - Science Summit News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Science Summit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Science Summit Today - Breaking & Trending Today
Reflex Molecular Testing May Enhance Targeted Therapy Benefit in Early-Stage Lung Cancer
Jobelle Baldonado, MD, highlights the emergence of targeted therapies and the need for reflex-ordered molecular testing in early-stage lung cancer.
Source: onclive.com
Updates to MDS Classification Complicate Yet Better Inform Treatment Navigation in MDS
Mikkael A. Sekeres, MD, MS, discusses the influence of therapeutic developments and conflicting classification systems on the management of MDS.
Source: onclive.com
Recent Approvals Across Hematologic Malignancies Usher in a New Era
Mikkael A. Sekeres, MD, MS, highlights recent approvals and emerging therapeutics in hematologic malignancies discussed by his colleagues.
Source: onclive.com
McAndrews Expands on the Evolving Treatment Armamentarium in HER2+ Breast Cancer
Nicholas P. McAndrew, MD, MSCE, discusses how updated clinical trial findings are shifting the treatment paradigm in HER2-positive metastatic breast cancer.
Source: onclive.com